Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Dolasetron Impurity 5

Dolasetron Impurity 5 is listed in the pharmaceutical impurity collection under CAS 115956-03-1. Its represented structure has formula C15H23NO5 and a calculated molecular weight of 297.35 g/mol.

2D chemical structure

O O N O O O

Chemical identity

Catalog name
Dolasetron Impurity 5
Common name
Dolasetron Impurity 5
Chemical name
ethyl 9-(2-ethoxy-2-oxoethyl)-7-oxo-9-azabicyclo[3.3.1]nonane-3-carboxylate
CAS
115956-03-1
SMILES
CCOC(=O)CN1C2CC(=O)CC1CC(C(=O)OCC)C2
InChI
InChI=1S/C15H23NO5/c1-3-20-14(18)9-16-11-5-10(15(19)21-4-2)6-12(16)8-13(17)7-11/h10-12H,3-9H2,1-2H3
InChIKey
JCXUVTNCQZYKOG-UHFFFAOYSA-N
Associated API
Dolasetron

Record ID: A297b965734fb

Computed properties

C15H23NO5 Molecular formula
297.351 g/molMolecular weight
297.1576 DaMonoisotopic exact mass
72.91 ŲTopological polar surface area
0.9247 Calculated LogP (Wildman–Crippen)
74.513 cm³/molMolar refractivity (Wildman–Crippen)
6 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 2 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 5 10 15 20 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight297.35143.33
Calculated LogP (Wildman–Crippen)0.924724.33
Topological polar surface area72.9152.37
Hydrogen-bond acceptors675.83
Hydrogen-bond donors011.28
Rotatable bonds (strict)560.59

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC15H23NO5dimensionless
Molecular weight297.351g/mol
Monoisotopic exact mass297.1576Da
Topological polar surface area72.91Ų
Calculated LogP (Wildman–Crippen)0.9247dimensionless
Molar refractivity (Wildman–Crippen)74.513cm³/mol
Hydrogen-bond acceptors6count
Hydrogen-bond donors0count
Rotatable bonds (strict)5count
Heavy atoms21count
Heteroatoms6count
Rings2count
Aromatic rings0count
Aliphatic rings2count
Saturated rings2count
Aromatic heterocycles0count
Aliphatic heterocycles2count
Saturated heterocycles2count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.8fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters2count
Unspecified atom stereocenters2count
Spiro atoms0count
Bridgehead atoms2count
Labute approximate surface area124.3083Ų
Valence electrons118count
Radical electrons0count
Bertz complexity404.287index
Balaban J2.0352index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Dolasetron Impurity 5

Qualification and safety assessment of Dolasetron Impurity 5

Explore toxicological qualification of Dolasetron Impurity 5 and ICH M7 mutagenic impurity assessment of Dolasetron Impurity 5 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Dolasetron Impurity 5 and acceptable intake and limit justification for Dolasetron Impurity 5. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Dolasetron Impurity 5

Explore Altox services and software through the Altox Pharma-Hub.